Uploaded September 2024 | Updated September 2026, 1 day ago

---

The MYC oncogene is notorious in the cancer research world because it is implicated in many advanced or aggressive cancers such as treatment-resistant prostate cancer. In this episode, Sarki Abdulkadir, MD, PhD, shares how his team bucked the conventional notion that the MYC gene is “undruggable” and uncovered a handful of compounds that block MYC gene activity, making prostate cancer tumors sensitive to hormone therapy and opening up a potential new therapeutic target for treatment-resistant prostate cancer.

Learn more: spr.ly/6000oBULQ

-----------------------------------------

Visit the Feinberg website: https://www.feinberg.northwestern.edu/

SUBSCRIBE: spr.ly/60073dxlv

TWITTER (X): spr.ly/60003dxmj
INSTAGRAM: spr.ly/60083dxWi
FACEBOOK: spr.ly/60063dxW0
LINKEDIN: spr.ly/60063dxqG